Letter to the Editor: Perspectives on mRNA Vaccine Development for Cancer.
J Interferon Cytokine Res
; 42(11): 592-593, 2022 11.
Article
in English
| MEDLINE | ID: covidwho-2231738
ABSTRACT
Recently, messenger ribonucleic acid (mRNA) vaccine research and development became a hotspot in the field of prevention and treatment of Corona Virus Disease 2019 (COVID-19) and some other disorders. mRNA vaccine shows many advantages over other vaccines, including cost-effectiveness, safety, and rapid optimization of antigen-specific sequences and shorter development cycle. Cancer progression is significantly associated with immune response, and mRNA vaccine also shows obvious advantages for cancer immunotherapy. In this study, we briefly summarize the recent advances and discuss the perspectives on tumor mRNA vaccine development; particularly, these findings pave an avenue for effective cancer prevention and treatment.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cancer Vaccines
/
COVID-19
/
Neoplasms
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Interferon Cytokine Res
Journal subject:
Allergy and Immunology
Year:
2022
Document Type:
Article
Affiliation country:
Jir.2022.0145
Similar
MEDLINE
...
LILACS
LIS